Y
LIVE

Serial Number

97126771

Owner

TopAlliance Biosciences Inc.

Attorney

John P. Rynkiewicz

Filing Date

Nov 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

Y Trademark

Serial Number: 97126771

Y is a trademark filed by TopAlliance Biosciences Inc. on November 16, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

TopAlliance Biosciences Inc. (2 trademarks)

Suite A-1
Menlo Park, CA 94025

Entity Type: 03

Trademark Details

Filing Date

November 16, 2021

Registration Date

Not Registered

Published for Opposition

June 20, 2023

Goods & Services

Pharmaceuticals preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; medical preparations for the treatment ofneurological, oncological and immunological diseases and disorders, and dietary supplements for human beings and animals, medical plasters and fungicides for use in oncology and immunology and for the treatment of infectious and metabolic diseases; veterinary pharmaceutical preparations containing biological or chemical therapeutics for use in oncology and immunology and for the treatment of infectious and metabolic diseases; sanitary preparations for medical purposes

Providing medical information in the field of pharmaceutical products, medicines, vaccines, healthcare, health issues, health awareness and treatment options; On-line information services, namely, providing health information to physicians, healthcare professionals and patients on the topics of health issues, pharmaceutical products and treatments; Providing medical information via a website; providing a website featuring medical information for oncology, immunology, infectious and metabolic diseases

Retail and wholesale store services in the field of pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel management consulting; business management and organization consultancy; retail and wholesale services by direct solicitation by sales agents in the field of oncology, immunology, infectious and metabolic diseases; import export agency services; marketing services

Business training; educational services, namely, conducting classes, seminars, conferences and webinars in the fields of oncology, immunology, infectious and metabolic diseases

Implementation of early assessment in new drug development fields to develop pharmaceutical preparations and medicines; scientific research and development; product quality testing; drug evaluation, in the nature of product quality evaluation, namely, drug discovery evaluation, drug developablity, drug efficacy, and drug metabolic kinetics for various biological or chemical therapeutics for oncology, immunology, infectious and metabolic diseases; pharmaceutical research services; biological research and analysis; technical research in the field of oncology, immunology, infectious and metabolic diseases; chemical research and analysis; bacteriological research and analysis; scientific research in the nature of conducting clinical trials for others; product research and development; scientific laboratory services

Surgical apparatus and instruments for treating various conditions related to oncology, immunology, infectious and metabolic diseases

Filing History

SOU TEAS EXTENSION RECEIVED
Feb 12, 2026 EEXT
TEAS STATEMENT OF USE RECEIVED
Feb 11, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2025 EXRA
SOU EXTENSION 4 GRANTED
Aug 12, 2025 EX4G
SOU EXTENSION 4 FILED
Aug 12, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 13, 2025 EXRA
SOU EXTENSION 3 GRANTED
Feb 13, 2025 EX3G
SOU EXTENSION 3 FILED
Feb 12, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 12, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 15, 2024 EXRA
SOU EXTENSION 2 GRANTED
Aug 15, 2024 EX2G
SOU EXTENSION 2 FILED
Aug 15, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 26, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jan 24, 2024 EX1G
SOU EXTENSION 1 FILED
Jan 24, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 24, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 15, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 20, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 20, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 31, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 19, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 19, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 19, 2023 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 16, 2023 GNFN
FINAL REFUSAL E-MAILED
Mar 16, 2023 GNFR
FINAL REFUSAL WRITTEN
Mar 16, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 27, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 27, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 27, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 26, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 24, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Nov 23, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2021 NWOS
NEW APPLICATION ENTERED
Nov 19, 2021 NWAP